Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/17/2009 | CA2180957C Cloning and recombinant production of crf receptor(s) |
02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
02/17/2009 | CA2138928C Immunoconjugates |
02/17/2009 | CA2121498C Recombitope peptides |
02/17/2009 | CA2120629C Production of gamma linolenic acid by a .delta.6-desaturase |
02/17/2009 | CA1341591C Detoxification of pertussis toxin |
02/12/2009 | WO2009021234A1 Methods of treatment and prevention of diet- induced obesity and sequelae thereof |
02/12/2009 | WO2009021163A2 Enhancing gene transfer |
02/12/2009 | WO2009021150A2 Platelet derived growth factor receptor supports cytomegalovirus infectivity |
02/12/2009 | WO2009021041A2 Rice metallothionein promoters |
02/12/2009 | WO2009021004A1 A plant regulatory region that directs transgene expression in the maternal and supporting tissue of maize ovules and pollinated kernels |
02/12/2009 | WO2009021000A2 Protein and dna sequence encoding a cold adapted subtilisin-like activity |
02/12/2009 | WO2009020899A1 Translation initiation region sequences for the optimal expression of heterologous proteins |
02/12/2009 | WO2009020894A2 RNAι-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
02/12/2009 | WO2009020848A2 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
02/12/2009 | WO2009020847A2 Rnai-related inhibition of tnfa signaling pathway for treatment of ocular angiogenesis |
02/12/2009 | WO2009020824A1 Polynucleotides encoding stop codons in multiple reading frames and methods of use |
02/12/2009 | WO2009020771A2 Rnai agents comprising universal nucleobases |
02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
02/12/2009 | WO2009020632A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
02/12/2009 | WO2009020609A2 Isolation of nucleic acids molecules using modified solid supports |
02/12/2009 | WO2009020528A1 Vacuolar pyrophosphatases and uses in plants |
02/12/2009 | WO2009020458A1 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
02/12/2009 | WO2009020435A1 Integrated microfluidic device for gene synthesis |
02/12/2009 | WO2009020403A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance |
02/12/2009 | WO2009020346A2 A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |
02/12/2009 | WO2009020344A2 Small interfering rnas (sirnas) controlling multiple target genes and method for preparing the same |
02/12/2009 | WO2009020337A2 A method for in vitro phosphorylation of trap of staphylococcus aureus and a method for screening the inhibitor of the trap phosphorylation |
02/12/2009 | WO2009020279A1 Preparing method for (s)-3-hydroxybutyric acid and (s)-3-hydroxybutyrate ester using recombinant microorganism |
02/12/2009 | WO2009020252A1 Mammary gland-specific human erythropoietin expression vector, transgenic animal and method for producing human erythropoietin using same |
02/12/2009 | WO2009020237A1 Method for producing rice plant resistant to rice dwarf virus by rna interference |
02/12/2009 | WO2009020236A2 Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene |
02/12/2009 | WO2009020231A1 Triterpene oxidase derived from plant belonging to genus glychyrrhiza, gene encoding the triterpene oxidase, and use of the protein or the gene |
02/12/2009 | WO2009020201A1 Isolated cell mass |
02/12/2009 | WO2009020197A1 Fluorescent protein with deep blue color |
02/12/2009 | WO2009020144A1 Method of producing heterogeneous protein |
02/12/2009 | WO2009020119A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor |
02/12/2009 | WO2009020101A1 Method for producing plant with modified flower morphology |
02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
02/12/2009 | WO2009020079A1 Primer set and probe for detection of human papillomavirus |
02/12/2009 | WO2009020028A1 Determination and suppression of expression level of g protein-coupled receptor kinase 4 gene in breast cancer cell |
02/12/2009 | WO2009019796A1 Method for producing rice resistant to rice dwarf virus by rna interference |
02/12/2009 | WO2009019614A2 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
02/12/2009 | WO2009019612A2 Lentiviral gene transfer vectors and their medicinal applications |
02/12/2009 | WO2009019528A1 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
02/12/2009 | WO2009019524A1 Genes and proteins for the biosynthesis of the lantibiotic 107891 |
02/12/2009 | WO2009019484A1 Crystal structure of ampk and uses thereof |
02/12/2009 | WO2009019465A1 Insulin-like growth factor fusion proteins |
02/12/2009 | WO2009019458A2 Erythropoietin fusion proteins |
02/12/2009 | WO2009019456A1 Interferon fusion proteins |
02/12/2009 | WO2009019433A2 Fertilisation protein |
02/12/2009 | WO2009019427A1 Leptin fusion proteins |
02/12/2009 | WO2009019260A2 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage |
02/12/2009 | WO2009019157A1 New proteases and detergent and cleaning agent comprising said new proteases |
02/12/2009 | WO2009019018A1 Enhancement of protein production in eukaryotic cells |
02/12/2009 | WO2009019007A2 Sdf-1 binding nucleic acids and the use thereof |
02/12/2009 | WO2009018989A1 Nucleotide sequences modulating the expression of genes in plants |
02/12/2009 | WO2009018739A1 Bacillus thuringiensis strain, cry8h genes, proteins, which are all highly toxic to order coleoptera insect pests, and uses thereof |
02/12/2009 | WO2009018667A1 Plant bioreactor for the production of interleukin-24 cytokine |
02/12/2009 | WO2009018622A1 Lactation-associated polypeptides |
02/12/2009 | WO2009018610A1 Cross-beta silk genes |
02/12/2009 | WO2009002937A3 Methods for isolating long fragment rna from fixed samples |
02/12/2009 | WO2008157350A3 Methods and materials for reducing biofilms |
02/12/2009 | WO2008156702A9 Bacteria mediated gene silencing |
02/12/2009 | WO2008153935A3 Methods for improving protein properties |
02/12/2009 | WO2008153712A3 Method for introducing nucleic acids into fungal cells |
02/12/2009 | WO2008153447A3 Convection polymerase chain reaction method |
02/12/2009 | WO2008153339A3 A vaccine for treating or preventing pasteurellosis using a yeast surface-expression system |
02/12/2009 | WO2008147470A3 Anaerobic synthesis of oxidized products by e. coli |
02/12/2009 | WO2008145603A3 Pharmaceutical compositions comprising telomerase, and uses thereof |
02/12/2009 | WO2008145400A3 Mutated structural protein of a parvovirus |
02/12/2009 | WO2008137751A3 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
02/12/2009 | WO2008133711A3 Random homozygous gene perturbation to enhance antibody production |
02/12/2009 | WO2008131828A3 Putative chloroplast transporter as novel specific kanamycin resistance marker |
02/12/2009 | WO2008131807A3 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
02/12/2009 | WO2008131191A8 Nucleic acids hybridizable to micro rna and precursors thereof |
02/12/2009 | WO2008127450A3 Linear expression cassette vaccines |
02/12/2009 | WO2008127283A3 Engineered metabolic pathways |
02/12/2009 | WO2008122770A3 Nucleic acids and libraries for use in functional analysis of regulatory rnas such as micrornas (mirnas) |
02/12/2009 | WO2008113847A3 Improved method for homologous recombination |
02/12/2009 | WO2008113770A3 Anti-androgen peptides and uses thereof in cancer therapy |
02/12/2009 | WO2008109495A3 Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof |
02/12/2009 | WO2008109454A4 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
02/12/2009 | WO2008102274A3 Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof |
02/12/2009 | WO2008100789A3 Compositions and methods for altering elastogenesis |
02/12/2009 | WO2008100481A3 Lung cancer-targeted peptides and applications thereof |
02/12/2009 | WO2008095057A3 Heat-stable carbonic anhydrases and their use |
02/12/2009 | WO2008093009A3 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
02/12/2009 | WO2008092081A3 Targeted delivery of sirna |
02/12/2009 | WO2008076158A3 Nontoxic ricin mutant compositions and methods |
02/12/2009 | WO2008073661A3 Long term disease modification using immunostimulatory oligonucleotides |
02/12/2009 | WO2008005988A3 Production of stilbenes and derivatives in plant hairy root cultures |
02/12/2009 | WO2007096882A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
02/12/2009 | WO2007075911A3 Inhibition of glycogen synthase kinase and methods of treating autoimmune or immune inflammatory disease |
02/12/2009 | WO2007049275A3 Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same |
02/12/2009 | WO2006036698A3 Modification of plant lignin content |
02/12/2009 | WO2005086798A3 Improved interleukin-2 muteins |
02/12/2009 | WO2005040107A3 Methods for making simvastatin and intermediates |
02/12/2009 | US20090044300 Method For Improving Productivity of Plant By Chloroplast Technology |
02/12/2009 | US20090044298 Transplastomic Plants Expressing Lumen-Targeted Protein |